News April 29, 2026
BURLINGTON, Mass. and JERUSALEM, Israel, April 29, 2026 — BrainsWay Ltd. (NASDAQ & TASE: BWAY)...
News April 15, 2026
Growing payer acceptance of nurse practitioner administration of Deep TMS is expected to expand access...
News March 26, 2026
BURLINGTON, Mass. and JERUSALEM, Israel, March 26, 2026 – BrainsWay Ltd. (NASDAQ & TASE: BWAY)...
Events May 9 - May 10, 2026
LONDON, UK
BrainsWay will be participating in the Longevity Med Summit 2026, taking place on May 9–10 in London,...
Events, News November 21, 2025
Deep TMS™ becomes first and only TMS device cleared in treatment of patients ages 15 to 86 suffering...
Events June 12 - June 14, 2025
BrainsWay is attending the CTMSS conference June 13th through June 14th, in San Diego, CA. We invite...
In the media November 24, 2025
Key takeaways: BrainsWay Deep TMS is cleared for use by adolescents and adults with major depressive...
In the media October 1, 2025
Serenity Mental Health Centers, one of the leading providers of Deep TMS treatment nationwide, commits...
In the media September 26, 2025
Coordinating transcranial magnetic stimulation (TMS) with ketamine therapy shows promising potential...
